Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.75 |
| ▸ | LMNA | P02545 | 3/20 | 0.75 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.75 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.75 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.60 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1006545 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1007211 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL7553266 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL95166 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL95801 | 1.00 | — | — | |
| SCHEMBL1006395 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1006840 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1008881 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1008155 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 | |
| SCHEMBL1006815 | 1.00 | TSHR (0.75) | TSHRLMNANFKB1PMP22GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114041459-B | Processing liquid for preserving natural primary colors of fresh cut camellia flowers and application thereof | 云南欣绿茶花股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| WO-2024126765-A1 | RNAI-BASED THERAPIES TARGETING CLAUDIN-1 FOR THE TREATMENT AND PREVENTION OF FIBROTIC DISEASES | UNIVERSITÉ DE STRASBOURG (FR) | 2024-06-20 | — | — | WO | disclosed |
| EP-4362956-A1 | LOW-MOLECULAR-WEIGHT HE800 EXOPOLYSACCHARIDE DERIVATIVES WITH ANTI-CANCER PROPERTIES AND USES THEREOF | Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER) (FR) | 2024-05-08 | — | — | EP | disclosed |
| US-20240116876-A1 | SOCE Inhibitors and Therapeutic Uses Thereof | Institut National de la Santé et de la Recherche Médicale (FR) | 2024-04-11 | — | — | US | disclosed |
| US-20240099976-A1 | BLENDED FORMULATIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2024-03-28 | — | — | US | disclosed |
| CN-115053371-B | Composite particle for electrochemical element, method for producing same, electrode for electrochemical element, and electrochemical element | 日本瑞翁株式会社 | 2024-02-13 | — | — | CN | disclosed |
| US-11826399-B2 | Chlorotoxin agents and uses thereof | EISAI INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230349922-A1 | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer | UNIVERSITÉ DE STRASBOURG (FR) | 2023-11-02 | — | — | US | disclosed |
| EP-3289074-B1 | CLINICAL GENE SIGNATURE-BASED HUMAN CELL CULTURE MODEL AND USES THEREOF | UNIV STRASBOURG (FR) | 2023-10-04 | — | — | EP | disclosed |
| US-20230233598-A1 | Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses | INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER) (FR) | 2023-07-27 | — | — | US | disclosed |
| US-4670100-A | Aqueous solutions or dispersions of polyisocyanate addition products, a process for their preparation, and their use as coating compounds or as sizing agents for paper | BAYER AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | disclosed |
| US-4636525-A | NONIONIC SURFACTANT | POLA CHEMICAL INDUSTRIES, INC. (JP) | 1987-01-13 | — | — | US | disclosed |
| EP-0187806-A1 | 2-CHLORO-ETHYL PHOSPHONIC ACID ESTERS AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | NITROKEMIA IPARTELEPEK (HU) | 1986-07-23 | — | — | EP | disclosed |
| US-4595537-A | Containing aliphatic alcohol or fatty acid residue | POLA CHEMICAL INDUSTRIES, INC. (JP) | 1986-06-17 | — | — | US | disclosed |
| WO-1986000903-A1 | 2-CHLORO-ETHYL PHOSPHONIC ACID ESTERS AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | NITROKÉMIA IPARTELEPEK (HU) | 1986-02-13 | — | — | WO | disclosed |
| EP-0049601-B1 | SUNSCREEN COMPOSITIONS CONTAINING DELTA-5,7 STEROIDAL DIENES | THE MASSACHUSETTS GENERAL HOSPITAL (US) | 1985-03-27 | — | — | EP | disclosed |
| US-4332690-A | GAS HYDRATE AND TETRABUTYLAMMONIUM SALT OR TETRAISOAMYLAMMONIUM SALT | MITSUBISHI DENKI KABUSHIKI KAISHA (JP) | 1982-06-01 | — | — | US | disclosed |
| EP-0049601-A2 | Sunscreen compositions containing delta-5,7 steroidal dienes | THE MASSACHUSETTS GENERAL HOSPITAL (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4310511-A | Sunscreen compositions containing Δ5,7 steroidal dienes | MASSACHUSETTS GENERAL HOSPITAL (US) | 1982-01-12 | — | — | US | disclosed |
| US-3933662-A | ALKALINE EARTH METAL CARBONATE, POLYOXYALKYLATED COMPOUNDS | CHEVRON RESEARCH COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116876-A1 | SOCE Inhibitors and Therapeutic Uses Thereof | STIM1, ORAI1, STIM2 | TSHR 2503/4885LMNA 2543/4885NFKB1 2138/4885 |
| US-11826399-B2 | Chlorotoxin agents and uses thereof | NRP1, LCP1, CLSPN | TSHR 2970/4885LMNA 4604/4885NFKB1 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.